Humacyte Total Current Assets from 2010 to 2025

HUMAW Stock  USD 1.05  0.07  6.25%   
Humacyte Total Current Assets yearly trend continues to be fairly stable with very little volatility. Total Current Assets are likely to outpace its year average in 2025. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2010-12-31
Previous Quarter
95.8 M
Current Value
132.7 M
Quarterly Volatility
40.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Humacyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Humacyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.7 M, Interest Expense of 1.2 M or Selling General Administrative of 21.1 M, as well as many indicators such as Price To Sales Ratio of 96.95, Dividend Yield of 0.0 or PTB Ratio of 20.49. Humacyte financial statements analysis is a perfect complement when working with Humacyte Valuation or Volatility modules.
  
Check out the analysis of Humacyte Correlation against competitors.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.

Latest Humacyte's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Humacyte over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Humacyte's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Humacyte's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Humacyte Total Current Assets Regression Statistics

Arithmetic Mean105,393,442
Geometric Mean99,510,417
Coefficient Of Variation38.15
Mean Deviation25,009,757
Median94,954,000
Standard Deviation40,209,655
Sample Variance1616.8T
Range187.9M
R-Value0.29
Mean Square Error1588.5T
R-Squared0.08
Significance0.28
Slope2,433,789
Total Sum of Squares24252.2T

Humacyte Total Current Assets History

2025132.7 M
202495.8 M
202383.3 M
2022154.2 M
2021229.3 M
202041.4 M

About Humacyte Financial Statements

Humacyte investors use historical fundamental indicators, such as Humacyte's Total Current Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Humacyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets95.8 M132.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Humacyte Stock Analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.